The board of directors of JW (Cayman) Therapeutics Co. Ltd. (the "Company", together with its subsidiaries, the "Group") announced the changes to the Board and the composition of the Board committees. The board announced that, with effect from December 3, 2021, (i) Mr. Hans Edgar Bishop ("Mr. Bishop") has resigned as a non-executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee"); and (ii) Mr. Yanling Cao ("Mr. Cao") has resigned as an independent non-executive Director and a member of the nomination committee of the Company (the "Nomination Committee"), due to their decisions to devote more time to their other commitments. Mr. Bishop will remain with the Company as a senior advisor. The Board further announced that, with effect from December 3, 2021, (i) Dr. Ann Li Lee, a non-executive Director, has been appointed as a member of the Remuneration Committee; and (ii) Mr. Kin Cheong Kelvin Ho, an independent non-executive Director, has been appointed as a member of the Nomination Committee.